220 related articles for article (PubMed ID: 32202774)
1. Origins of the Increased Affinity of Phosphorothioate-Modified Therapeutic Nucleic Acids for Proteins.
Hyjek-Składanowska M; Vickers TA; Napiórkowska A; Anderson BA; Tanowitz M; Crooke ST; Liang XH; Seth PP; Nowotny M
J Am Chem Soc; 2020 Apr; 142(16):7456-7468. PubMed ID: 32202774
[TBL] [Abstract][Full Text] [Related]
2. Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.
Liang XH; Shen W; Sun H; Kinberger GA; Prakash TP; Nichols JG; Crooke ST
Nucleic Acids Res; 2016 May; 44(8):3892-907. PubMed ID: 26945041
[TBL] [Abstract][Full Text] [Related]
3. Phosphorothioate modified oligonucleotide-protein interactions.
Crooke ST; Vickers TA; Liang XH
Nucleic Acids Res; 2020 Jun; 48(10):5235-5253. PubMed ID: 32356888
[TBL] [Abstract][Full Text] [Related]
4. Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides.
Østergaard ME; De Hoyos CL; Wan WB; Shen W; Low A; Berdeja A; Vasquez G; Murray S; Migawa MT; Liang XH; Swayze EE; Crooke ST; Seth PP
Nucleic Acids Res; 2020 Feb; 48(4):1691-1700. PubMed ID: 31980820
[TBL] [Abstract][Full Text] [Related]
5. Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index.
Shen W; De Hoyos CL; Migawa MT; Vickers TA; Sun H; Low A; Bell TA; Rahdar M; Mukhopadhyay S; Hart CE; Bell M; Riney S; Murray SF; Greenlee S; Crooke RM; Liang XH; Seth PP; Crooke ST
Nat Biotechnol; 2019 Jun; 37(6):640-650. PubMed ID: 31036929
[TBL] [Abstract][Full Text] [Related]
6. Interaction of ASOs with PC4 Is Highly Influenced by the Cellular Environment and ASO Chemistry.
Vickers TA; Migawa MT; Seth PP; Crooke ST
J Am Chem Soc; 2020 May; 142(21):9661-9674. PubMed ID: 32374993
[TBL] [Abstract][Full Text] [Related]
7. Binding of phosphorothioate oligonucleotides with RNase H1 can cause conformational changes in the protein and alter the interactions of RNase H1 with other proteins.
Zhang L; Vickers TA; Sun H; Liang XH; Crooke ST
Nucleic Acids Res; 2021 Mar; 49(5):2721-2739. PubMed ID: 33577678
[TBL] [Abstract][Full Text] [Related]
8. Site-specific replacement of phosphorothioate with alkyl phosphonate linkages enhances the therapeutic profile of gapmer ASOs by modulating interactions with cellular proteins.
Migawa MT; Shen W; Wan WB; Vasquez G; Oestergaard ME; Low A; De Hoyos CL; Gupta R; Murray S; Tanowitz M; Bell M; Nichols JG; Gaus H; Liang XH; Swayze EE; Crooke ST; Seth PP
Nucleic Acids Res; 2019 Jun; 47(11):5465-5479. PubMed ID: 31034558
[TBL] [Abstract][Full Text] [Related]
9. Structures of annexin A2-PS DNA complexes show dominance of hydrophobic interactions in phosphorothioate binding.
Hyjek-Składanowska M; Anderson BA; Mykhaylyk V; Orr C; Wagner A; Poznański JT; Skowronek K; Seth P; Nowotny M
Nucleic Acids Res; 2023 Feb; 51(3):1409-1423. PubMed ID: 36124719
[TBL] [Abstract][Full Text] [Related]
10. Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides.
Wang S; Allen N; Vickers TA; Revenko AS; Sun H; Liang XH; Crooke ST
Nucleic Acids Res; 2018 Apr; 46(7):3579-3594. PubMed ID: 29514240
[TBL] [Abstract][Full Text] [Related]
11. Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins.
Shen W; De Hoyos CL; Sun H; Vickers TA; Liang XH; Crooke ST
Nucleic Acids Res; 2018 Mar; 46(5):2204-2217. PubMed ID: 29390093
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Phosphorus and Non-Phosphorus Neutral Oligonucleotide Backbones for Enhancing Therapeutic Index of Gapmer Antisense Oligonucleotides.
Vasquez G; Migawa MT; Wan WB; Low A; Tanowitz M; Swayze EE; Seth PP
Nucleic Acid Ther; 2022 Feb; 32(1):40-50. PubMed ID: 34698585
[TBL] [Abstract][Full Text] [Related]
13. Nucleic acid binding proteins affect the subcellular distribution of phosphorothioate antisense oligonucleotides.
Bailey JK; Shen W; Liang XH; Crooke ST
Nucleic Acids Res; 2017 Oct; 45(18):10649-10671. PubMed ID: 28977508
[TBL] [Abstract][Full Text] [Related]
14. The Combination of Mesyl-Phosphoramidate Inter-Nucleotide Linkages and 2'-
Zhang L; Liang XH; De Hoyos CL; Migawa M; Nichols JG; Freestone G; Tian J; Seth PP; Crooke ST
Nucleic Acid Ther; 2022 Oct; 32(5):401-411. PubMed ID: 35861704
[TBL] [Abstract][Full Text] [Related]
15. Re-Engineering RNA Molecules into Therapeutic Agents.
Egli M; Manoharan M
Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
[TBL] [Abstract][Full Text] [Related]
16. Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotides.
Wang S; Sun H; Tanowitz M; Liang XH; Crooke ST
Nucleic Acids Res; 2017 May; 45(9):5309-5322. PubMed ID: 28379543
[TBL] [Abstract][Full Text] [Related]
17. Fatty Acid-Modified Gapmer Antisense Oligonucleotide and Serum Albumin Constructs for Pharmacokinetic Modulation.
Hvam ML; Cai Y; Dagnæs-Hansen F; Nielsen JS; Wengel J; Kjems J; Howard KA
Mol Ther; 2017 Jul; 25(7):1710-1717. PubMed ID: 28641935
[TBL] [Abstract][Full Text] [Related]
18. Golgi-endosome transport mediated by M6PR facilitates release of antisense oligonucleotides from endosomes.
Liang XH; Sun H; Hsu CW; Nichols JG; Vickers TA; De Hoyos CL; Crooke ST
Nucleic Acids Res; 2020 Feb; 48(3):1372-1391. PubMed ID: 31840180
[TBL] [Abstract][Full Text] [Related]
19. Lipid Conjugates Enhance Endosomal Release of Antisense Oligonucleotides Into Cells.
Wang S; Allen N; Prakash TP; Liang XH; Crooke ST
Nucleic Acid Ther; 2019 Oct; 29(5):245-255. PubMed ID: 31158063
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the interactions of chemically-modified therapeutic nucleic acids with plasma proteins using a fluorescence polarization assay.
Gaus HJ; Gupta R; Chappell AE; Østergaard ME; Swayze EE; Seth PP
Nucleic Acids Res; 2019 Feb; 47(3):1110-1122. PubMed ID: 30566688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]